EC Healthcare (UNHLF) Stock Price & Analysis
EC Healthcare (UNHLF) — price $0.086 (0.00%), as of the Nov 19, 2026 trading session; market cap $101M.
Educational signal · not a buy or sell recommendation · How to read this
EC Healthcare · UNHLF
EC Healthcare is an investment holding company providing medical and healthcare services across Hong Kong, Macau, and mainland China. The company operates through medical, aesthetic medical and beauty, and other segments, offering a range of services from beauty treatments to medical surgeries.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.086 | |
| Change on the day | 0.00% | |
| 52-week range | $0.086 – $0.086 | |
| Market capitalisation | $101M | |
| Shares traded on the day | 10.0K |
Price & events
Other perspectives
Council score for EC Healthcare (UNHLF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is EC Healthcare (UNHLF), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. EC Healthcare (UNHLF) is the company analyzed here. It employs 2,400 people and is led by Lyn Wade Lu. In Q4 FY2026 it reported revenue of HK$1.84B and net income of -HK$392M. The market values it at $101M.
What do the latest results show for EC Healthcare (UNHLF)?
Short answer · as of
The most recent reported quarter, Q4 FY2026, carried revenue of HK$1.84B. Against analyst estimates the company has EPS beat 1 of the last 5 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2026 | HK$1.84B | -HK$392M | -HK$0.33 (diluted) |
| Q2 FY2026 | HK$1.93B | -HK$10M | -HK$0.01 (diluted) |
| Q4 FY2025 | HK$2.08B | -HK$181M | -HK$0.15 (diluted) |
| Q2 FY2025 | HK$2.06B | HK$14M | HK$0.01 (diluted) |
What are the financial strengths and risks for EC Healthcare (UNHLF)?
Short answer · as of
The distress and quality screens read Altman Z 1.04 · Piotroski F 3. Trailing ratios: ROE -25.4% · ROA -9.3% · current ratio 0.91 · earnings yield -61.8% · free-cash-flow yield 93.8%.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of 1.04 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-25.4%) — the business is not currently generating profit on shareholder capital.
- Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 5 reported quarters.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held UNHLF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported UNHLF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
EC Healthcare Stock: Key Questions Answered
These answers are editorial: 1 of these 8 answers is drawn from the UNHLF research dossier (written Mar 16, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is UNHLF a good stock to buy?
Stock Expert AI does not rate UNHLF buy, sell or hold. EC Healthcare has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the UNHLF stock price today?
The last price recorded for EC Healthcare (UNHLF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for UNHLF?
EC Healthcare faces several key risks. Intense competition in the healthcare and beauty industries could limit its market share and pricing power.
What are the key factors to evaluate for UNHLF?
Evaluate UNHLF on fundamentals, analyst consensus, and risk factors. EC Healthcare operates in three segments: Medical, Aesthetic Medical and Beauty and Wellness, and Others, providing diversified revenue streams. Not financial advice.
How frequently does UNHLF data refresh on this page?
UNHLF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven UNHLF's recent stock price performance?
EC Healthcare (UNHLF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offerings across medical and aesthetic fields. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider UNHLF overvalued or undervalued right now?
EC Healthcare (UNHLF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research UNHLF before investing?
Before investing in EC Healthcare (UNHLF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 14 figures on this page — 8 from Financial Modeling Prep (FMP) and 6 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com